Insmed (INSM) Cash from Investing Activities Growth (3y) (2013 - 2026)
Insmed (INSM) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Insmed |
19.79 Bn |
18.57 Bn |
258.54 Mn |
85.49% |
| Date | Value |
|---|
| Mar 31, 2026 |
85.49% |
| Dec 31, 2025 |
167.65% |
| Sep 30, 2025 |
-159.25% |
| Jun 30, 2025 |
331.70% |
| Mar 31, 2025 |
40.83% |
| Dec 31, 2024 |
65.98% |
| Sep 30, 2024 |
-392.48% |
| Jun 30, 2024 |
-24.86% |
| Mar 31, 2024 |
531.69% |
| Dec 31, 2023 |
47.21% |
| Sep 30, 2023 |
126.16% |
| Jun 30, 2023 |
-426.26% |
| Mar 31, 2023 |
159.77% |
| Dec 31, 2022 |
52.66% |
| Sep 30, 2022 |
75.30% |
| Jun 30, 2022 |
35.07% |
| Mar 31, 2022 |
-193.08% |
| Dec 31, 2021 |
-120.91% |
| Sep 30, 2021 |
-65.57% |
| Jun 30, 2021 |
-6.97% |
